It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In patients with heart failure (HF) who suffered in-hospital cardiac arrest (IHCA), little is known about the characteristics, survival and neurological outcome. We used the Swedish Registry of Cardiopulmonary Resuscitation to study this, including patients aged ≥ 18 years suffering IHCA (2008–2019), categorised as HF alone, HF with acute myocardial infarction (AMI), AMI alone, or other. Odds ratios (OR) for 30-day survival, trends in 30-day survival, and the implication of HF phenotype was studied. 6378 patients had HF alone, 2111 had HF with AMI, 4210 had AMI alone. Crude 5-year survival was 9.6% for HF alone, 12.9% for HF with AMI and 34.6% for AMI alone. The 5-year survival was 7.9% for patients with HF and left ventricular ejection fraction (LVEF) ≥ 50%, 15.4% for LVEF < 40% and 12.3% for LVEF 40–49%. Compared with AMI alone, adjusted OR (95% CI) for 30-day survival was 0.66 (0.60–0.74) for HF alone, and 0.49 (0.43–0.57) for HF with AMI. OR for 30-day survival in 2017–2019 compared with 2008–2010 were 1.55 (1.24–1.93) for AMI alone, 1.37 (1.00–1.87) for HF with AMI and 1.30 (1.07–1.58) for HF alone. Survivors with HF had good neurological outcome in 92% of cases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Gothenburg, Institute of Medicine, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582)
2 University of Glasgow, British Heart Foundation (BHF) Cardiovascular Research Centre, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X)
3 University of Gothenburg, Institute of Medicine, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582); University of Borås, Prehospen-Centre for Prehospital Research, Borås, Sweden (GRID:grid.412442.5) (ISNI:0000 0000 9477 7523)
4 Kalmar County Hospital, Department of Internal Medicine, Division of Cardiology, Region Kalmar County, Sweden (GRID:grid.413799.1) (ISNI:0000 0004 0636 5406); Linnaeus University, Faculty of Health and Life Sciences, Kalmar, Sweden (GRID:grid.8148.5) (ISNI:0000 0001 2174 3522)
5 Karolinska Institute, Department of Medicine, Center for Resuscitation Science, Solna, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
6 University of Borås, Prehospen-Centre for Prehospital Research, Borås, Sweden (GRID:grid.412442.5) (ISNI:0000 0000 9477 7523); The Swedish Registry of Cardiopulmonary Resuscitation, Gothenburg, Sweden (GRID:grid.412442.5)
7 University of Gothenburg, Institute of Medicine, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582); The Swedish Registry of Cardiopulmonary Resuscitation, Gothenburg, Sweden (GRID:grid.8761.8)